Amanote Research

Amanote Research

    RegisterSign In

Reducing Cardiovascular Risk Using Genomic Information in the Era of Precision Medicine

Circulation - United States
doi 10.1161/circulationaha.116.021765
Full Text
Open PDF
Abstract

Available in full text

Categories
Cardiovascular MedicinePhysiologyCardiology
Date

March 22, 2016

Authors
Pradeep NatarajanChristopher J. O’Donnell
Publisher

Ovid Technologies (Wolters Kluwer Health)


Related search

Radiopharmaceutical Therapy in the Era of Precision Medicine

European Journal of Cancer
Cancer ResearchOncology
2014English

Structural Valve Degeneration in the Era of Precision Medicine

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2019English

Imaging of Histiocytosis in the Era of Genomic Medicine

Radiographics
MedicineNuclear MedicineRadiologyImaging
2019English

Development of Cures in the Era of Genomic Medicine

Journal of Developing Drugs
2012English

An Integrated Clinical and Genomic Information System for Cancer Precision Medicine

BMC Medical Genomics
Genetics
2018English

Heritable Cancer Risk in the Genomic Era

Pathology
Forensic MedicinePathology
2020English

Challenges and Future in Precision Cardiovascular Medicine

Cardiovascular Prevention and Pharmacotherapy
2019English

Personalized Cancer Medicine: Next Steps in the Genomic Era

Cellular Oncology
MedicineCancer ResearchOncologyMolecular Medicine
2015English

Chronic Lymphocytic Leukaemia Genomics and the Precision Medicine Era

British Journal of Haematology
Hematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy